November 2017 Sales Summary
In a continuation from last month’s patterns, we see that sales are once again, unfortunately, terrible across the board for Marvel. Almost all comic books examined here had decreases, most of which were in the double digits. And as of the time of this article, six of the series listed below have been cancelled. The glow of Legacy’s promises have worn off, and the few series that saw their Legacy banner premiers in November had the same rise-and-fall sales as we saw in October with tons of other series. Absolutely none of the series we’ve reviewed thus far have seen any noticeable sales improvement thanks to Legacy. As many comic professionals predicted, Marvel Legacy turned out to be a big gimmick that didn’t draw in new readers or appease the innumerable fans Marvel has lost in the past few years.
Before going further, a few caveats:
As always, these numbers reflect estimated comics shipped to North American comic shops; it does not measure individual comic sales to readers like you and me, cover anything outside of North America, and it ignores digital sales entirely.
As such, it was expected that comic shops would have stocked up on Marvel books to accompany Legacy’s launch, so there’s no surprise that many books had initial massive jumps in sales.
In addition, not all Marvel properties have received Legacy banners yet; comic shops evidently stocked up on those books that are carrying Legacy monikers with this month’s issues, at the detriment to otherwise popular and successful books released this month that haven’t reached their Legacy starting points yet.
And lastly, like all things in life, numbers have no correspondence to the quality of these books. Lots of these books, even those that are “poor selling” are phenomenal works. So please don’t be discouraged if your favorite books are low on a sales list somewhere.
Old Man Logan #30, the last installment for “Days of Anger,” had a 5% sales decrease over the previous issue. But the follow-up issue, #31, was the series premier under the Legacy banner, which brought with it a 61% sales increase to clear 60,000 units, the best sales the series has seen since issue #2.
X-Men Gold #15 and #16, X-Men Blue #15 and #16, Deadpool vs. Old Man Logan #2, and Astonishing X-Men #5 had sales in the high 30,000s, but each had a sales drop over their previous issues between 2% and 8%.
Weapon X #11 had the lone sales increase of all the non-Legacy X-books, with a jump of 8.6% for the conclusion of the Hulkverine arc(s). The issue sold about 36,000 units.
All-New Wolverine #27 and Cable #151 had sales decreases over their previous issues, both selling between 20,000 and 30,000 units.
And our three remaining series – Jean Grey #9, Iceman #7, and Generation X #8 and #9 – each failed to break the 20,000 mark. All three series have now been cancelled; their final issues will be released between January and March of 2018.
Avengers #673 (featuring young Cyclops) and Despicable Deadpool #289 (featuring Cable) both had sales decreases but still cleared 30,000 units.
Secret Warriors #8 (featuring Magik) had a sales boost thanks to its premier under the Legacy banner, seeing a 140% sales increase. The follow-up issue, however, failed to clear 10,000 units. The series has been cancelled.
Uncanny Avengers #29 (featuring Rogue and Beast) and Champions #14 (featuring young Cyclops) sold between 21,000 and 24,000 units each; Uncanny Avengers has also been cancelled.
Iron Fist #74 (featuring Sabertooth), Hawkeye #12 (featuring Wolverine and Honey Badger), and U.S. Avengers #12 (featuring Sunspot and Cannonball) each sold between 12,000 and 17,000 units. All three series had decreases, Hawkeye has been cancelled, and this was the final issue of U.S. Avengers.
Other Marvel Legacy Titles
Mighty Thor #700 appears to be the best-selling single issue to come out of Legacy aside from the Marvel Legacy #1 one-shot. With sales high enough to chart in both October and November 2017, the total units moved for this issue are 125,442, surpassing Amazing Spider-Man #789 (110,349).
At this point, most Marvel titles have released at least two issues under Legacy, and we can see both the giant sales boosts and the colossal drops for all of them. Every single series that has released at least two books under Legacy has had a double-digit sales decrease, including: Venom(-65%), Amazing Spider-Man (-52%), Incredible Hulk (-56%), Luke Cage (-70%), Captain Marvel(-63%), Guardians of the Galaxy (-54%), Mighty Thor (-65%), Invincible Iron Man (-56%), Iron Fist(-63%), Black Panther (-57%), America (-68%), Defenders (-53%), Jessica Jones (-55%), Monsters Unleashed (-71%), Royals (-67%), Spider-Gwen (-69%), Spider-Man and Deadpool (-49%), and Unbelievable Gwenpool (-63%).
For several series, sales are worse now than they were before Legacy began, and of these, many are big name, power-house titles. These include: Amazing Spider-Man, Avengers, Mighty Thor, Invincible Iron Man, Black Panther, America, Champions, Defenders, Jessica Jones,Monsters Unleashed, Royals, Secret Warriors, Spider-Gwen, Spider-Man and Deadpool, U.S. Avengers, and Uncanny Avengers.
In all, of the 48 series examined for this article, the most recent issues sold in the following ranges: 3 series sold under 10,000; 13 series sold between 10,000-20,000; 12 series sold between 20,000-30,000; 10 series sold between 30,000-40,000; and 10 series sold greater than 40,000. Of these 10 series selling beyond 40,000, all but two of them (Mighty Thor and Amazing Spider-Man) reached these numbers with a premier under the Legacy banner.
Numbers used in this article come from ComicChron, with remaining tables and graphics created by me.http://www.comichron.com/monthlycomicssales/2017/2017-11.html.